- P-ISSN 1225-0163
- E-ISSN 2288-8985
- Log In/Sign Up
- P-ISSN1225-0163
- E-ISSN2288-8985
- SCOPUS, ESCI, KCI
Article Detail
Home > Article Detail
Establishment of content criteria of marker compounds through the monitoring of Achyranthis Radix collected from Korea and China
Analytical Science and Technology / Analytical Science and Technology, (P)1225-0163; (E)2288-8985
2012, v.25 no.4, pp.250-256
https://doi.org/10.5806/AST.2012.25.4.250
&
(2012). Establishment of content criteria of marker compounds through the monitoring of Achyranthis Radix collected from Korea and China. Analytical Science and Technology, 25(4), 250-256, https://doi.org/10.5806/AST.2012.25.4.250
- Downloaded
- Viewed
Abstract
Two marker compounds of Achyranthis Radix, ecdysterone and inokosterone, were analyzed by HPLC on an ODS column (250 × 4.6 mm, 5 μm) with a mobile phase of 15% acetonitrile containing 0.08% formic acid at a flow rate of 1.0 mL/min and a detection wavelength of UV 254 nm. The method was validated by ICH guideline and applied to the monitoring of marker compounds in 93 samples of Achyranthis Radix collected at various areas in Korea and China. The new content criteria of ecdysterone and inokosterone, established using linear regression method were 0.033% and 0.020%, respectively. When the new content criteria were applied to the quality control test of commercial Achyranthis Radix, 95.4% of total samples including 100%of Korean and 92.6% of Chinese samples were passed the test. Application of new content criteria could protect the Korean products and decrease the distribution of Chinese products with lower quality.
- keywords
- content criteria, ecdysterone, inokosterone, Achyranthis Radix, HPLC
Reference
1
1. Korea Food and Drug Administration, Korean Pharmacopoeia IX, Seoul, p.958, 2007.
2
2. The Minister of Health, Labour and Welfare of Japan, Japanese Pharmacopoeia 15 Ed., p.1268, 2006.
3
3. Chinese Pharmacopoeia Commission, Pharmacopoeia of the People’s Republic of China, p.67, 2010.
4
4. Korea Pharmacognosy Soc., Pharmacognosy, Dongmyungsa, p.166, 2010.
5
5. H. S. Choi, M. J. Lee, M. S. Na, M. Y. Lee and D. B. Choi, J. Ind. Eng. Chem., 15(2), 275-280 (2009).
6
6. F. Wang, T. Ogata and I. Tomohiro, Technol. Med., 2(1), 24-28 (2009).
7
7. U. Bhosale, R. Yennanarayan, P. Prachi, M. Zambare and R. S. Somani, Annals. Neurosci., 18, 44-47 (2011).
8
8. N. C. Neogi, R. D. Garg and R. S. Rathor, Indian J. Pharm., 32(2), 43-6 (1970).
9
9. S. B. Han, C. W. Lee, Y. D. Yoon, J. H. Lee, J. S. Kang, K. H. Lee, W. K. Yoon, K. Lee, S. K. Park and H. M. Kim, Arch. Pharm. Res., 28(8), 902-8 (2005).
10
10. T. Lu, C. Mao, L. Zhang and W. Xu, Zhong Yao Cai, 20(10), 507-9 (1997).
11
11. Y. O. Kim, S. W. Lee and S. E. Lee, Kor. J. Med. Crop., 17(6), 470-4 (2009).
12
12. S. Yu, Y. Zhang, Zhonghua Zhong Liu Za Zhi, 17(4), 275-8 (1995).
13
13. D. B. Xiang and X. Y. Li, Zhongguo Yao Li Xue Bao, 14(6), 556-61 (1993).
14
14. X. M. Chen and G. Y. Tian, Carbohydr. Res., 338(11), 1235-41 (2003).
15
15. S. D. Lee and K. S. Kim, J. Kor. Acup. Mox. Soc., 16(3), 287-315 (1999).
16
16. W. S. Do, K. H. Kim and K. S. Kim, J. Kor. Acup. Mox. Soc., 18(1), 157-169 (2001).
17
17. S. M. Jung, S. I. Choi, S. M. Park and T. R. Heo, Kor. J. Food Sci. Technol., 39(5), 564-8 (2007).
18
18. J. H. Kim, J. Y. Ki, J. Y. Ann, H. J. Park, H. J. Kim, H. B. Kwak, J. M. Oh and Y. K. Kim, Kor. J. Herbol., 25(1), 65-74 (2010).
19
19. F. Xie, X. Li, Sun. K, Y. Chu, H. Cao, N. Chen, W. Wang, M. Liu, W. Liu and D. Mao, J. Tradit. Chin. Med., 21(3), 225-31 (2001).
20
20. J. Li, H. J. Li, P. Li and H. Qi, Biomed. Chromatogr., 21(8), 823-828 (2007).
21
21. K. H. Son, J. H. Hwang, S. H. Lee, J. H. Park, S. J. Kang, S. Y. Chang and K. S. Lee, Kor. J. Pharmacogn., 30, 335-339 (1999).
22
22. Ratra, S. Parminder, Curr. Trends. Life Sci., 4(Adv. Ecol.), 81-5 (1979).
23
23. M. F. Marcone, F. Jahaniaval, H. Aliee and Y. Kakuda, Food Chem., 81, 7-12 (2003).
24
24. S. Ogawa, A. Yoshida and K. Reiko, Chem. Pharm. Bull., 25(5), 904-8 (1977).
25
25. J. Li, H, Qi, L. W. Qi, L. Yi and P. Li, Anal. Chim. Acta., 596(2), 264-272 (2007).
26
26. J. Li, P. Li, H. J. Li, Y. Song, Z. M. Bi and Y. J. Li, J. Sep. Sci., 30(6), 843-850 (2007).
27
27. X. H. Ding, Fenxi Ceshi Xuebao, 19(5), 53-55 (2000).
28
28. Korea Food and Drug Administration, Guidelines for the establishment of concentration limit for crude drugs, Seoul, 2007.
29
29. J. S. Kang and Y. S. Jang, Korea patent, 10-2011-0030475.
Other articles from this issue
- Gas chromatographic profiles of rose essential oils: a round-robin test on oil of rose, Chinese Kushui type (Rosa sertata × Rosa rugosa)
- Analysis of biodiesel quality based on infrared spectroscopy and multivariate statistics
- Signal compensation by the light scattering of sample aerosols in ICP-AES
- The study of quantitative analysis for noxious gases of plastic materials by remote sensing open path FT-IR spectrometer
- Determination of hazardous semi-volatile organic compounds in industrial wastewater using disk-type solid-phase extraction and GC-MS
- Study on distribution characteristics of brominated flame retardants in sediments
- Establishment of content criteria of marker compounds through the monitoring of Achyranthis Radix collected from Korea and China
- Residue analysis of penicillines in livestock and marine products
- more
Recommanded Articles
This website recommended the use the Chrome browser for journal website.